samsung biologics 207940 Algorithm Investment Report

1. Performance Analysis of Algorithm (Separate) 207940 Date
Period 3 months 100-m won
2016.12 2017.12 2018.12 Average 2018.12 2019.03 2019.06 2019.09 2019.12 2020.03
IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep)
Sales 2,946 4,646 5,358 4,317 1,783 1,254 781 1,848 2,184 2,469 1,417
O-profit -304 660 557 304 115 -234 -154 236 333 329 -9
N-income -1,768 -970 2,241 -166 3,173 -385 -134 441 761 1,369 774
O-rate -10.3 14.2 10.4 4.8 6.4 -18.7 -19.7 12.8 15.3 13.3 1.6
N-rate -60.0 -20.9 41.8 -13.0 178.0 -30.7 -17.2 23.9 34.8 55.4 40.7
ROE -4.3 -2.4 5.4 -0.5 30.5 13.4 14.2 15.6 16.2 17.2 17.9
Debt-ratio 84.5 80.6 43.9 69.7 43.9 43.0 42.0 39.5 38.1 36.8 40.6
Quick-ratio 52.4 18.0 176.7 82.4 176.7 172.3 153.0 120.9 112.3 108.1 140.6
reserve-ratio 2,365.2 2,306.5 2,416.6 2,362.8 2,416.6 2,393.3 2,385.2 2,411.9 2,410.6 2,409.3 2,404.5
EPS -2,672 -1,466 3,387 -250 4,796 -582 -203 667 1,150 2,069 1,169
BPS 61,700 60,100 62,805 61,535 62,805 62,216 62,013 62,683 62,644 62,606 62,429
Dividends 0 0 0 0
2020-01-06
Major
Financial
Information
Recent Annual Performance Recent quarterly performance Estimate
Average
Gap
(Indication /
stock)
Color
High price ~ 21 %
High mid ~ 5 %
Mid ~ -12 %
Low mid ~ -28 %
Low price ~ -45 %
Normal
227,145 W 227,145 W 0 W
Industrial name of the company
The number of
All industries
Algorithm
Industry ranking
Total number of
listed companies
Algorithm
company ranking
Investment
opinion
Pharmaceutical 81 40 3,009 839
430,681 W 430,681 W 362,835 W
362,835 W 362,835 W 294,990 W Evaluation
498,526 W 498,526 W~ 430,681 W
411,500 W
46.5294,990 W 294,990 W 227,145 W
High mid
Indication price Range Current stock price Company score
227,145원
294,990원
362,835원
430,681원
498,526원
High mid
411,500원
-45%
-28%
-12%
4.7%
21.1%
-50%
-40%
-30%
-20%
-10%
0.%
10.%
20.%
30.%
0W
100,000W
200,000W
300,000W
400,000W
500,000W
600,000W
Low price Low mid Mid High mid High price
Indication price chart (Separate)
Indication price
samsung biologics
Gap
samsung biologics

2. [Price for scheduled purchasing]
Arbitrarily made
Algorithm stocks Trading Strategies (Separate) 207940 Date
Period
Gap
(Indication /
stock)
Color
low price 227,145 W 227,145 W ~ 0 W -45 % 658,948 W 3
Low mid 294,990 W 294,990 W ~ 227,145 W -28 % 416,446 W 1
Mid 362,835 W 362,835 W ~ 294,990 W -12 % 173,944 W 0
High mid 430,681 W 430,681 W ~ 362,835 W 5 % -68,558 W -0
Suggested Purchase
Amount 1,470,839 W
Number of stocks
purchased 4
Indication price Range Buying / Selling Buying / Selling [Stocks]
High price 498,526 W 498,526 W~ ~ 430,681 W 21 % -311,060 W -1
2020-01-06
3 months
Current stock price Evaluation
Stock price rise
probability score
Investment opinion Prospective purchase amount
411,500 W High mid 62.9 Normal 3,500,000 W
Stock price rise
probability score
A Sector 47.7 49.9 48.4 47.3 50.8 54.4
62.9B Sector 36.3 12.9 47.3 47.3 36.7 60.4
Total average 42.0 31.4 46.1 56.7 43.7 57.4
2019.08.06 2019.09.04 2019.10.07 2019.11.05 2019.12.03 2020.01.03
2019.10.07 2019.11.05 2019.12.03 2020.01.03
Total of
increase rate
Total score
A Sector 4 % -3 % -2 % 7 % 7 %
2 % 49.7B Sector -181 % 70 % 7 % -29 % 39 %
Total average -34 % 32 % 19 % -30 % 24 %
2019.09.04
4% -3% -2% 7% 7%
-181%
70%
7%
-29%
39%
-34%
32%
19%
-30%
24%
-200%
-150%
-100%
-50%
0%
50%
100%
2019.09.04 2019.10.07 2019.11.05 2019.12.03 2020.01.03
Increase rate of stock price rise
A sector
B sector
Total average
samsung biologics
48 50 48 47
51
54
36
13
44
47
37
60
42
31
46
57
44
57
0
10
20
30
40
50
60
70
2019.08.06 2019.09.04 2019.10.07 2019.11.05 2019.12.03 2020.01.03
Stock price rise probability score
A sector
B sector
Total average

3. do not
the
Compliance notice
① The information provided by The Algorithm Company Analysis
Consulting is obtained through reliable data and information and
The Algorithm Company Analysis Program (TACAP), but its
accuracy or completeness are not guaranteed. Furthermore, it
may change over time.Therefore, we are not legally responsible
for the results of the data provided by The Algorithm Company
Analysis Consulting because of information errors or omissions.
② The Algorithm Company Analysis Consulting and all the
information provided on it site are reference materials for
investment decisions and the final responsibility of investment is
up to users utilizing this information.
③ The Algorithm Company Analysis Consulting and its site do not
do anything that violates the related laws such as discretionary
transaction.
④ Users can not reallocate and recycle the information provided
by The Algorithm Company Analysis Consulting firm let alone the
information provided by its Site.
⑤ Be sure to know about application period of this algorithm
analysis report in order to improve its accuracy.
Tel : 070 - 4667 - 5009 Email : tacac@tacac.co.kr
Homepage : tacac.co.kr Blog : tacac.blog.me
SERVICES
M&A, IPO, RECOVER, CORPORATE RESTRUCTURING, MANAGEMENT OF
TECHNOLOGY, BUSINESS STRATEGY, FAMILY BUSINESS
Request : http://tacac.co.kr/?page_id=1374